Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 7Terminated 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 431Carcinoma, Non-Small-Cell Lung 372Neoplasms 324Prostatic Neoplasms 244Leukemia, Myeloid, Acute 230Multiple Myeloma 229Neoplasm Metastasis 215Melanoma 200Lung Neoplasms 178Leukemia 172Lymphoma 170Colorectal Neoplasms 157Pancreatic Neoplasms 151Lymphoma, Non-Hodgkin 150Recurrence 149Ovarian Neoplasms 143Leukemia, Lymphocytic, Chronic, B-Cell 134Precursor Cell Lymphoblastic Leukemia-Lymphoma 131Myelodysplastic Syndromes 121Carcinoma, Renal Cell 120Lymphoma, Large B-Cell, Diffuse 111Lymphoma, Follicular 108Brain Neoplasms 99Squamous Cell Carcinoma of Head and Neck 96Head and Neck Neoplasms 96Glioblastoma 92Urinary Bladder Neoplasms 88Carcinoma, Hepatocellular 80Hodgkin Disease 73Colonic Neoplasms 73

Interventions

Metformin 1Doxorubicin 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Has results × Cardiotoxicity × Clear all
NCT03862131 2025-07-29

PROACT

Washington University School of Medicine

Phase 2 Terminated
49 enrolled 12 charts
BreastLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Sarcoma, Neoplasms, Plasma Cell, Cardiotoxicity

NCT02472353 2019-10-16

Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer

Avera McKennan Hospital & University Health Center

Phase 2 Terminated
30 enrolled 10 charts
Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

NCT02674204 2019-05-15

STOP

Cedars-Sinai Medical Center

Phase 2 Terminated
2 enrolled 7 charts
Breast

Breast Neoplasms, Heart Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡